{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:49:17Z","timestamp":1783104557539,"version":"3.54.6"},"reference-count":83,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002726","name":"Beijing Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-051952"],"award-info":[{"award-number":["HL-051952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG049770"],"award-info":[{"award-number":["R01AG049770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL074318"],"award-info":[{"award-number":["R01HL074318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AG0737-01"],"award-info":[{"award-number":["R21 AG0737-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970303"],"award-info":[{"award-number":["81970303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e17851","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T21:02:31Z","timestamp":1688158951000},"page":"e17851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased CaMKII activation and contrast changes of cardiac \u03b21-and \u03b23-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension"],"prefix":"10.1016","volume":"9","author":[{"given":"Xiaoqiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"VonCannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-6868","authenticated-orcid":false,"given":"Heng Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3954-3793","authenticated-orcid":false,"given":"Che Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e17851_bib1","first-page":"727","article-title":"[Influence of risk factors for cardiovascular diseases, history of cardiovascular diseases, and structural and functional state of the heart on 3-year survival in persons 95 years and older","volume":"34","author":"Eruslanova","year":"2021","journal-title":"Adv. Gerontol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib2","article-title":"Milestones in heart failure: how far we have come and how far we have left to go","volume":"13","author":"Gajjela","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.heliyon.2023.e17851_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/RES.0b013e3182582523","article-title":"Animal models of heart failure: a scientific statement from the American Heart Association","volume":"111","author":"Houser","year":"2012","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17851_bib4","first-page":"36","article-title":"The renin-angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts","volume":"2022","author":"Ferrario","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.heliyon.2023.e17851_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcvm.2019.00163","article-title":"Activation of the human angiotensin-(1-12)-chymase pathway in rats with human angiotensinogen gene transcripts","volume":"6","author":"Ferrario","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.heliyon.2023.e17851_bib6","doi-asserted-by":"crossref","first-page":"H995","DOI":"10.1152\/ajpheart.00833.2015","article-title":"Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene","volume":"310","author":"Ferrario","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib7","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1073\/pnas.89.16.7806","article-title":"Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes","volume":"89","author":"Ganten","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2023.e17851_bib8","first-page":"1009","article-title":"[Development of a model of human renin hypertension in rats]","volume":"89","author":"Bohlender","year":"1996","journal-title":"Arch. Mal. Coeur. Vaiss."},{"key":"10.1016\/j.heliyon.2023.e17851_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.HYP.29.1.428","article-title":"High human renin hypertension in transgenic rats","volume":"29","author":"Bohlender","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e17851_bib10","doi-asserted-by":"crossref","first-page":"32497","DOI":"10.1016\/S0021-9258(18)31662-4","article-title":"Functional expression of the human angiotensinogen gene in transgenic mice","volume":"269","author":"Yang","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e17851_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/circ.142.suppl_3.12731","article-title":"Abstract 12731: acute calcium\/calmodulin-dependent protein kinase II inhibition augments cardiomyocyte contractility and improves \u03b2-adrenergic regulation in experimental hypertension of transgenic rats expressing human angiotensinogen gene","volume":"142","author":"Sun","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/circ.142.suppl_3.13451","article-title":"Abstract 13451: upregulation of CaMKII and contrast changes of cardiac \u03b21- and \u03b23-adrenergic signaling pathways in a humanized angiotensinogen model of hypertension","volume":"142","author":"Cheng","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-016-2801-3","article-title":"Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle","volume":"422","author":"De Mello","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2023.e17851_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170714","article-title":"Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension","volume":"149","author":"Ferrario","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.heliyon.2023.e17851_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2019.09.052","article-title":"Angiotensin-(1-12)\/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen","volume":"297","author":"Reyes","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fphar.2020.00035","article-title":"Challenges and opportunities for therapeutic targeting of calmodulin kinase II in heart","volume":"11","author":"Nassal","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fphar.2014.00021","article-title":"CaMKII inhibitors: from research tools to therapeutic agents","volume":"5","author":"Pellicena","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138161282104141204124129","article-title":"Targeting cardiomyocyte Ca2+ homeostasis in heart failure","volume":"21","author":"Roe","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2023.e17851_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lfs.2019.01.010","article-title":"Chronic CaMKII inhibition reverses cardiac function and cardiac reserve in HF mice","volume":"219","author":"He","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e17851_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-018-0732-x","article-title":"Inhibition of calcium\/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats","volume":"17","author":"Daniels","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001949","article-title":"Calcium\/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function","volume":"4","author":"Prasad","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2023.e17851_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.RES.84.6.713","article-title":"Identification and expression of delta-isoforms of the multifunctional Ca2+\/calmodulin-dependent protein kinase in failing and nonfailing human myocardium","volume":"84","author":"Hoch","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yjmcc.2019.12.002","article-title":"Ca(2+)\/calmodulin-dependent protein kinase II is essential in hyperacute pressure overload","volume":"138","author":"Baier","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.RES.0000069685.20258.F1","article-title":"Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release","volume":"92","author":"Maier","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00421-011-1994-0","article-title":"Chronic CaMKII inhibition blunts the cardiac contractile response to exercise training","volume":"112","author":"Kaurstad","year":"2012","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yjmcc.2007.06.013","article-title":"Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban","volume":"43","author":"Kemi","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib28","first-page":"1940","article-title":"Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice","volume":"119","author":"Chelu","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2023.e17851_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.120.000361","article-title":"Chronic Ca(2+)\/calmodulin-dependent protein kinase II inhibition rescues advanced heart failure","volume":"377","author":"Liu","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e17851_bib30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/CIRCRESAHA.110.220418","article-title":"Inhibition of elevated Ca2+\/calmodulin-dependent protein kinase II improves contractility in human failing myocardium","volume":"107","author":"Sossalla","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","article-title":"Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1139\/y00-045","article-title":"The negative inotropic action of catecholamines role of beta 3 adrenoceptors","volume":"78","author":"Gauthier","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib33","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1073\/pnas.90.8.3665","article-title":"Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3-\/beta2-adrenergic receptor","volume":"90","author":"Liggett","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2023.e17851_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI118823","article-title":"Functional beta 3-adrenoceptor in the human heart","volume":"98","author":"Gauthier","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2023.e17851_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/hh1901.098042","article-title":"Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium","volume":"89","author":"Cheng","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib36","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI2191","article-title":"The negative inotropic effect of beta 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle","volume":"102","author":"Gauthier","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2023.e17851_bib37","doi-asserted-by":"crossref","first-page":"H2425","DOI":"10.1152\/ajpheart.01045.2003","article-title":"Endogenous beta 3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure","volume":"286","author":"Morimoto","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1527-3466.2002.tb00079.x","article-title":"Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy","volume":"20","author":"Moniotte","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.heliyon.2023.e17851_bib39","doi-asserted-by":"crossref","first-page":"H923","DOI":"10.1152\/ajpheart.00371.2012","article-title":"\u03b23-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure","volume":"305","author":"Masutani","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115384","article-title":"Role of Gi proteins in the regulation of blood pressure and vascular remodeling","volume":"208","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/01.HYP.26.5.725","article-title":"G protein alterations in hypertension and aging","volume":"26","author":"Feldman","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e17851_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/157340310793566046","article-title":"Modulation of Gi proteins in hypertension: role of angiotensin II and oxidative stress","volume":"6","author":"Anand-Srivastava","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e17851_bib43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yjmcc.2009.10.016","article-title":"Beta-adrenergic receptor signaling in the heart: role of CaMKII","volume":"48","author":"Grimm","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib44","doi-asserted-by":"crossref","first-page":"A9022","DOI":"10.1161\/circ.144.suppl_1.9022","article-title":"Abstract 9022: chronic beta3-adrenergic receptor antagonist therapy rescues diabetic cardiomyopathy through Ca2+\/calmodulin-dependent protein kinase II inhibition in a type II diabetes murine model","volume":"144","author":"Cheng","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib45","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1073\/pnas.0813013106","article-title":"The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload","volume":"106","author":"Backs","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2023.e17851_bib46","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0006-291X(91)92031-E","article-title":"The newly synthesized selective Ca2+\/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells","volume":"181","author":"Sumi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2023.e17851_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2018.03.066","article-title":"Critical role of the chymase\/angiotensin-(1-12) axis in modulating cardiomyocyte contractility","volume":"264","author":"Li","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2019.09.004","article-title":"Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: assessment by pressure-volume analysis","volume":"301","author":"Li","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1755-5922.2010.00255.x","article-title":"Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991","volume":"30","author":"Zeng","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.heliyon.2023.e17851_bib50","article-title":"Abstract 17062: is up-regulation of beta3-adrenergic receptor (AR) in the failing myocardium detrimental or beneficial?--effect on chronic beta3-AR blockade in pacing-induced heart failure","volume":"122","author":"Cheng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2015.11.040","article-title":"Overexpression myocardial inducible nitric oxide synthase exacerbates cardiac dysfunction and beta-adrenergic desensitization in experimental hypothyroidism","volume":"204","author":"Shao","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0008-6363(98)00166-7","article-title":"Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy","volume":"39","author":"Suzuki","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10870-018-0739-x","article-title":"The crystal structure of N-[(2E)-3-(4-Chlorophenyl)prop-2-en-1-yl]-4-methoxy-N-methylbenzenesulfonamide","volume":"49","author":"Carrozzini","year":"2019","journal-title":"J. Chem. Crystallogr."},{"key":"10.1016\/j.heliyon.2023.e17851_bib54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1530-0277.2010.01194.x","article-title":"Up-regulation and functional effect of cardiac \u03b23-adrenoreceptors in alcoholic monkeys","volume":"34","author":"Cheng","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib55","doi-asserted-by":"crossref","first-page":"H1328","DOI":"10.1152\/ajpheart.00538.2010","article-title":"Local angiotensin II aggravates cardiac remodeling in hypertension","volume":"299","author":"Xu","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib56","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00219.2016","article-title":"Intracrine angiotensin II functions originate from noncanonical pathways in the human heart","volume":"311","author":"Ferrario","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tem.2007.05.001","article-title":"The intracellular renin-angiotensin system: a new paradigm","volume":"18","author":"Kumar","year":"2007","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/hh0901.089882","article-title":"Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function","volume":"88","author":"Serneri","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(03)00121-6","article-title":"Effect of extracellular and intracellular angiotensins on heart cell function; on the cardiac renin-angiotensin system","volume":"114","author":"De Mello","year":"2003","journal-title":"Regul. Pept."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e17851_bib60","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1038\/sj.jhh.1001351","article-title":"Electrical activity of the heart and angiotensin-converting enzyme inhibitors on the hyperpolarising action of enalapril","volume":"16","author":"De Mello","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e17851_bib61","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.peptides.2011.06.018","article-title":"On the local cardiac renin angiotensin system. Basic and clinical implications","volume":"32","author":"De Mello","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.heliyon.2023.e17851_bib62","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib63","doi-asserted-by":"crossref","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.112.201889","article-title":"Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension","volume":"61","author":"Moniwa","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e17851_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajh\/hps090","article-title":"Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats","volume":"26","author":"Varagic","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e17851_bib66","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1152\/physrev.00018.2010","article-title":"CaMKII in the cardiovascular system: sensing redox states","volume":"91","author":"Erickson","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e17851_bib67","doi-asserted-by":"crossref","first-page":"H1454","DOI":"10.1152\/ajpheart.00812.2011","article-title":"CaMKII inhibition in heart failure, beneficial, harmful, or both","volume":"302","author":"Cheng","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib68","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1172\/JCI39262","article-title":"CaMKII and a failing strategy for growth in heart","volume":"119","author":"Anderson","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2023.e17851_bib69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2004.04.026","article-title":"Role of Ca2+\/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure","volume":"63","author":"Zhang","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2023.e17851_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.yjmcc.2019.01.001","article-title":"CaMKII signaling in heart diseases: emerging role in diabetic cardiomyopathy","volume":"127","author":"Hegyi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003840","article-title":"Calcium\/calmodulin-dependent protein kinase II activity persists during chronic beta-adrenoceptor blockade in experimental and human heart failure","volume":"10","author":"Dewenter","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.heliyon.2023.e17851_bib72","doi-asserted-by":"crossref","first-page":"H199","DOI":"10.1152\/ajpheart.00387.2012","article-title":"Ca2+\/calmodulin-dependent protein kinase II increases the susceptibility to the arrhythmogenic action potential alternans in spontaneously hypertensive rats","volume":"307","author":"Mitsuyama","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e17851_bib73","first-page":"I96","article-title":"Hypertrophic phenotype of cardiac calcium\/calmodulin-dependent protein kinase II is reversed by angiotensin converting enzyme inhibition","volume":"97","author":"Hempel","year":"2002","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yjmcc.2015.06.007","article-title":"CaMKII\u03b4 mediates \u03b2-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic \u03b2-adrenergic stimulation","volume":"85","author":"Grimm","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib75","article-title":"Abstract 10246: chronic beta3-adrenergic receptor antagonist therapy rescues diabetic cardiomyopathy through Ca2+\/calmodulin-dependent protein kinase II inhibition","volume":"140","author":"Cheng","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e17851_bib76","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11906-022-01229-x","article-title":"Does the naked emperor parable apply to current perceptions of the contribution of renin angiotensin system inhibition in hypertension?","volume":"24","author":"Ferrario","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.heliyon.2023.e17851_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijcard.2014.11.179","article-title":"Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: a number-needed-to-treat analysis","volume":"181","author":"Brugts","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib78","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0000605-200912150-00162","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease","volume":"151","author":"Baker","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e17851_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003840","article-title":"Calcium\/calmodulin-dependent protein kinase II activity persists during chronic \u03b2-adrenoceptor blockade in experimental and human heart failure","volume":"10","author":"Dewenter","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.heliyon.2023.e17851_bib80","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3565(24)37893-0","article-title":"KN-93, an inhibitor of multifunctional Ca++\/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart","volume":"287","author":"Anderson","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e17851_bib81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0022-3565(24)35019-0","article-title":"Inhibitors of calmodulin-dependent protein kinase are nonspecific blockers of voltage-dependent K+ channels in vascular myocytes","volume":"290","author":"Ledoux","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e17851_bib82","doi-asserted-by":"crossref","first-page":"H752","DOI":"10.1152\/ajpheart.00347.2016","article-title":"Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart","volume":"312","author":"Warren","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2023.e17851_bib83","doi-asserted-by":"crossref","first-page":"20675","DOI":"10.1074\/jbc.M109.088617","article-title":"Effective post-insult neuroprotection by a novel Ca(2+)\/calmodulin-dependent protein kinase II (CaMKII) inhibitor","volume":"285","author":"Vest","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023050594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023050594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:57:38Z","timestamp":1766170658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023050594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023050594"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17851","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased CaMKII activation and contrast changes of cardiac \u03b21-and \u03b23-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17851"}}